Skip to main content

Advertisement

Log in

Preoperative factors associated with lateral lymph node metastasis in lower rectal cancer and the evaluation of the middle rectal artery

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

This study aimed to identify cases in which lateral lymph node (LLN) dissection (LLND) can be excluded by clarifying preoperative factors, including an evaluation of the middle rectal artery (MRA), associated with LLN metastasis.

Methods

Fifty-five consecutive patients who underwent preoperative positron emission tomography–computed tomography (PET/CT) and total mesorectal excision with LLND for rectal cancer were included. We retrospectively investigated the preoperative clinical factors associated with pathological LLN (pLLN) metastasis. We analyzed the regions of pLLN metastasis using MRA.

Results

pLLN metastasis occurred in 13 (23.6%) patients. According to a multivariate analysis, clinical LLN (cLLN) metastasis based on short-axis size and LLN status based on PET/CT were independent preoperative factors of pLLN metastasis. The negative predictive value (NPV) was high (97.1%) in patients evaluated as negative based on PET/CT and cLLN short-axis size. MRA was detected in 24 patients (43.6%) using contrast-enhanced CT, and there was a significant relationship between pLLN metastasis and the presence of MRA. pLLN metastasis in the internal iliac region but not in the obturator region was significantly correlated with the presence of MRA.

Conclusion

Combined cLLN metastasis based on short-axis size and PET/CT showed a higher NPV, suggesting this to be a useful method for identifying cases in which LLND can be excluded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008;15:729–37. https://doi.org/10.1245/s10434-007-9696-x.

    Article  PubMed  Google Scholar 

  2. Sluckin TC, Hazen SJA, Kusters M. From, “East vs West” towards international multidisciplinary collaboration: an appraisal of lateral lymph nodes in rectal cancer. Ann Gastroenterol Surg. 2021;5:731–7. https://doi.org/10.1002/ags3.12490.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, et al. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): A multicenter, randomized controlled, noninferiority trial. Ann Surg. 2017;266:201–7. https://doi.org/10.1097/SLA.0000000000002212.

    Article  PubMed  Google Scholar 

  4. Saito S, Fujita S, Mizusawa J, Kanemitsu Y, Saito N, Kinugasa Y, et al. Male sexual dysfunction after rectal cancer surgery: results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212. Eur J Surg Oncol. 2016;42:1851–8. https://doi.org/10.1016/j.ejso.2016.07.010.

    Article  CAS  PubMed  Google Scholar 

  5. Ito M, Kobayashi A, Fujita S, Mizusawa J, Kanemitsu Y, Kinugasa Y, et al. Urinary dysfunction after rectal cancer surgery: results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212). Eur J Surg Oncol. 2018;44:463–8. https://doi.org/10.1016/j.ejso.2018.01.015.

    Article  PubMed  Google Scholar 

  6. Yukimoto R, Uemura M, Tsuboyama T, Hata T, Fujino S, Ogino T, et al. Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study. BMC Cancer. 2021;21:520. https://doi.org/10.1186/s12885-021-08278-6.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Fujita S, Yamamoto S, Akasu T, Moriya Y. Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer. Int J Colorectal Dis. 2009;24:1085–90. https://doi.org/10.1007/s00384-009-0704-4.

    Article  PubMed  Google Scholar 

  8. Hamabe A, Ishii M, Onodera K, Okita K, Nishidate T, Okuya K, et al. MRI-detected extramural vascular invasion potentiates the risk for pathological metastasis to the lateral lymph nodes in rectal cancer. Surg Today. 2021;51:1583–93. https://doi.org/10.1007/s00595-021-02250-4.

    Article  PubMed  Google Scholar 

  9. Iwasa Y, Koyama F, Marugami N, Kuge H, Nakamoto T, Obara S, et al. The middle rectal artery detected by contrast-enhanced magnetic resonance imaging predicts lateral lymph node metastasis in lower rectal cancer. Int J Colorectal Dis. 2021;36:1677–84. https://doi.org/10.1007/s00384-021-03887-w.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Suzuki Y, Sasaki T, Hasegawa H, Ikeda K, Teramura K, Tsukada Y, et al. Morphological characteristics of lateral pelvic lymph nodes in locally advanced lower rectal cancer: a retrospective study. Ann Gastroenterol Surg. 2022;6:795–803. https://doi.org/10.1002/ags3.12590.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kasai S, Shiomi A, Kagawa H, Hino H, Manabe S, Yamaoka Y, et al. The effectiveness of machine learning in predicting lateral lymph node metastasis from lower rectal cancer: a Single Center development and validation study. Ann Gastroenterol Surg. 2022;6:92–100. https://doi.org/10.1002/ags3.12504.

    Article  PubMed  Google Scholar 

  12. Blair JB, Holyoke EA, Best RR. A note on the lymphatics of the middle and lower rectum and anus. Anat Rec. 1950;108:635–44. https://doi.org/10.1002/ar.1091080402.

    Article  CAS  PubMed  Google Scholar 

  13. Bell S, Sasaki J, Sinclair G, Chapuis PH, Bokey EL. Understanding the anatomy of lymphatic drainage and the use of blue-dye mapping to determine the extent of lymphadenectomy in rectal cancer surgery: unresolved issues. Colorectal Dis. 2009;11:443–9. https://doi.org/10.1111/j.1463-1318.2009.01769.x.

    Article  CAS  PubMed  Google Scholar 

  14. Sato K, Sato T. The vascular and neuronal composition of the lateral ligament of the rectum and the rectosacral fascia. Surg Radiol Anat. 1991;13:17–22. https://doi.org/10.1007/BF01623135.

    Article  CAS  PubMed  Google Scholar 

  15. Bilhim T, Pereira JA, Tinto HR, Fernandes L, Duarte M, O’Neill JE, et al. Middle rectal artery: myth or reality? Retrospective study with CT angiography and digital subtraction angiography. Surg Radiol Anat. 2013;35:517–22. https://doi.org/10.1007/s00276-012-1068-y.

    Article  PubMed  Google Scholar 

  16. Jones OM, Smeulders N, Wiseman O, Miller R. Lateral ligaments of the rectum: an anatomical study. Br J Surg. 1999;86:487–9. https://doi.org/10.1046/j.1365-2168.1999.01080.x.

    Article  CAS  PubMed  Google Scholar 

  17. Nano M, Dal Corso HM, Lanfranco G, Ferronato M, Hornung JP. Contribution to the surgical anatomy of the ligaments of the rectum. Dis Colon Rectum. 2000;43:1592–7; discussion 1597–8. https://doi.org/10.1007/BF02236746

  18. Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020; https://doi.org/10.1007/s10147-019-01485-z

  19. Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol. 2019;37:33–43. https://doi.org/10.1200/JCO.18.00032.

    Article  CAS  PubMed  Google Scholar 

  20. Kiyomatsu T, Ishihara S, Murono K, Otani K, Yasuda K, Nishikawa T, et al. Anatomy of the middle rectal artery: a review of the historical literature. Surg Today. 2017;47:14–9. https://doi.org/10.1007/s00595-016-1359-8.

    Article  PubMed  Google Scholar 

  21. Komori K, Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Shiomi A, et al. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): the analysis of data from the clinical trial (JCOG0212). Eur J Surg Oncol. 2019;45:336–40. https://doi.org/10.1016/j.ejso.2018.11.016.

    Article  PubMed  Google Scholar 

  22. Hatano S, Ishida H, Ishiguro T, Kumamoto K, Ishibashi K, Mochiki E, et al. Prediction of metastasis to mesorectal, internal iliac and obturator lymph nodes according to size criteria in patients with locally advanced lower rectal cancer. Jpn J Clin Oncol. 2015;45:35–42. https://doi.org/10.1093/jjco/hyu162.

    Article  PubMed  Google Scholar 

  23. Schaap DP, Boogerd LSF, Konishi T, Cunningham C, Ogura A, Garcia-Aguilar J, et al. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes. Br J Surg. 2021;108:205–13. https://doi.org/10.1093/bjs/znaa009.

    Article  CAS  PubMed  Google Scholar 

  24. Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol. 2006;13:397–404. https://doi.org/10.1245/ASO.2006.04.042.

    Article  PubMed  Google Scholar 

  25. Bassi MC, Turri L, Sacchetti G, Loi G, Cannillo B, La Mattina P, et al. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys. 2008;70:1423–6. https://doi.org/10.1016/j.ijrobp.2007.08.043.

    Article  PubMed  Google Scholar 

  26. Ishihara S, Kawai K, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, et al. Diagnostic value of FDG-PET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Tech Coloproctol. 2018;22:347–54. https://doi.org/10.1007/s10151-018-1779-0.

    Article  CAS  PubMed  Google Scholar 

  27. Fujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, et al. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012;13:616–21. https://doi.org/10.1016/S1470-2045(12)70158-4.

    Article  PubMed  Google Scholar 

  28. Ishibe A, Ota M, Watanabe J, Suwa Y, Suzuki S, Kanazawa A, et al. Prediction of lateral pelvic lymph-node metastasis in low rectal cancer by magnetic resonance imaging. World J Surg. 2016;40:995–1001. https://doi.org/10.1007/s00268-015-3299-7.

    Article  PubMed  Google Scholar 

  29. Kawahara H, Nimura H, Watanabe K, Kobayashi T, Kashiwagi H, Yanaga K. Where does the first lateral pelvic lymph node receive drainage from? Dig Surg. 2007;24:413–7. https://doi.org/10.1159/000108323.

    Article  PubMed  Google Scholar 

  30. Watanabe J, Ohya H, Sakai J, Suwa Y, Goto K, Nakagawa K, et al. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study. Tech Coloproctol. 2023;27:759–67. https://doi.org/10.1007/s10151-023-02761-x.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors have not received financial support from any funding sources for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Makoto Sohda.

Ethics declarations

Conflict of interest

The authors declare no conflicts of Interests for this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shiraishi, T., Ogawa, H., Yamaguchi, A. et al. Preoperative factors associated with lateral lymph node metastasis in lower rectal cancer and the evaluation of the middle rectal artery. Surg Today (2024). https://doi.org/10.1007/s00595-024-02868-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00595-024-02868-0

Keywords

Navigation